Press Releases Oramed Pharmaceuticals Inc. Deutsche Boerse AG

Equities

OJU1

US68403P2039

Market Closed - Deutsche Boerse AG Other stock markets 02:31:15 2024-05-02 am EDT			5-day change	1st Jan Change
2.157 ^EUR	-3.83%		-0.09%	+3.16%

Mar. 19	Oramed Pharmaceuticals Inc. Appoints Yehuda Reznick as Director, Effective as of April 1, 2024	CI
Mar. 06	Oramed Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Oramed Pharmaceuticals : 13D-Nadav Kidron	Mar. 26	PU
Oramed Pharmaceuticals : Update on the receipt of payments for the Scilex transaction	Mar. 19	PU
Oramed Pharmaceuticals : Other Report or Announcement	Mar. 18	PU
Oramed Pharmaceuticals : Other Report or Announcement	Mar. 18	PU
Oramed Pharmaceuticals : Other Report or Announcement	Jan. 02	PU
Oramed Pharmaceuticals : Other Report or Announcement	Dec. 24	PU
Oramed Pharmaceuticals : Form 8-K - Director Appointment- Dr. Daniel Aghion, effective as of January 1, 2024.	Dec. 19	PU
Oramed: Q3 Earnings Snapshot	Nov. 10	AQ
Oramed Pharmaceuticals : Other Report or Announcement	23-08-07	PU
Oramed Pharmaceuticals : Stalking Horse Stock Purchase Term Sheet - Form 8-K	23-08-07	PU
Oramed Signs Term Sheet with HTIT to Create a Joint Venture to Advance Oral Drug Delivery Technology Globally	23-08-02	PR
Oramed to Present at the 83rd American Diabetes Association Conference	23-06-21	AQ
Oramed to Present at Novel Therapies for Type 2 Diabetes & Obesity Summit	23-05-18	PR
Oramed: Q1 Earnings Snapshot	23-05-12	AQ
ORAMED PHARMACEUTICALS INC. : Change in Directors or Principal Officers (form 8-K)	23-05-01	AQ
Oramed Appoints Ben Shapiro to its Board of Directors	23-05-01	PR
ORAMED PHARMACEUTICALS INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-K)	23-03-06	AQ
ORAMED PHARMACEUTICALS INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	23-02-27	AQ
Oramed Pharmaceuticals Issues Shareholder Update	23-02-09	PR
Oramed Pharmaceuticals : Current Report - Form 8-K	23-01-12	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Oramed Pharmaceuticals Inc. Deutsche Boerse AG

Equities

OJU1

US68403P2039

Press Releases

Filters